Home › Bronchiolitis Obliterans Syndrome › District of Columbia
Bronchiolitis Obliterans Syndrome clinical trials in District of Columbia
3 studies for Bronchiolitis Obliterans Syndrome are looking for participants at sites in District of Columbia.
Cities in District of Columbia
A Study of Belumosudil in Children With Chronic Graft Versus Host Disease (schoolROCK)
- Children's National Medical Center - Washington- Site Number : 8400005, Washington D.C.
RecruitingPhase 2
Ages 1 to 18 · All sexes · Updated Sep 22, 2026 · NCT07116031A Study to Evaluate Axatilimab Versus Best Available Therapy in Pediatric Participants With Chronic Graft-Versus-Host Disease After at Least 2 Prior Lines of Systemic Therapy (AGAVE-256)
- Childrens National Medical Center, Washington D.C.
RecruitingPhase 2
Ages 2 to 17 · All sexes · Updated Sep 15, 2026 · NCT07124078A Study to Evaluate Axatilimab and Corticosteroids as Initial Treatment for Chronic Graft-Versus-Host Disease
- Childrens National Hospital, Washington D.C.
RecruitingPhase 3
Ages 12 and older · All sexes · Updated Sep 15, 2026 · NCT06585774From ClinicalTrials.gov, data retrieved Oct 6, 2026. Each study sets its own eligibility; the study team decides who can join.